GSA 2025 Abstract
Improving ADRD Diagnosis in Primary Care: Tailoring Blood-Based Biomarker Education for Low-Literacy Populations
Abstract
An estimated 50–70% of symptomatic patients with Alzheimer’s Disease and Related Dementias (ADRD) go unrecognized or are misdiagnosed in primary care, delaying access to supportive services, financial and residential planning, clinical trials, and potentially disease-modifying therapies.
